奥兰沙平;注射后综合征;药理动力学:大轮/A案例研究
Johanne Rozema1, Cornelis Paul van Stee2, Daniel J Touw1
1Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, University of Groningen, the Netherlands.
Therapeutic drug monitoring
|February 25, 2025
概括
本案例研究详细介绍了一个患者经历了严重的注射后狂妄/镇静综合征 (PDSS) 后的奥兰扎宾仓库注射. 治疗药物监测显示,奥兰扎的半衰期延长,有助于恢复和指导未来的治疗决策.
科学领域:
- 药理学 药理学是指药理学的学科.
- 临床毒理学 临床毒理学
- 精神病学是一个精神病学.
背景情况:
- 奥兰沙平是一种第二代抗精神病药物,用于治疗精神分裂症.
- 缓慢释放的肌肉内存配方是常见的.
- 注射后狂妄/镇静综合征 (PDSS) 是一种罕见但严重的不良反应.
研究的目的:
- 为了介绍PDSS的病例研究后奥兰zapine仓库注射.
- 在患有PDSS的患者中详细说明 olanzapine 的药理动力学.
- 突出治疗药物监测在PDSS管理中的作用.
主要方法:
- 一个64岁的男性患者出现PDSS症状的病例报告.
- 连续测量血清中的 olanzapine 水平 (第0,1,3,12天).
- 药物动力学分析,包括计算 olanzapine 半衰期.
主要成果:
- 患者呈现高血压,低心率和狂妄症,血清 olanzapine 水平达到 390 mcg/L.
- 计算的延长奥兰扎宾半衰期为7天.
- 症状在72小时内消失;实现完全康复.
结论:
- 这一案例强调了识别和管理PDSS的重要性.
- 治疗药物监测对于理解PDSS中 olanzapine 的药理动力学至关重要.
- 监测帮助确定安全恢复药物使用.
相关概念视频
Psychosis: Goals of Pharmacotherapy
102
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
102
Antiepileptic Drugs: Potassium Channel Activators
140
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
140
Nonlinear Pharmacokinetics: Drug Elimination for IV Bolus Injection
36
In pharmacokinetics, the elimination rate of a drug following a capacity-limited model is primarily controlled by two parameters: Vmax and KM. These parameters are crucial in how the drug behaves inside the body after administration.
Following the administration of a single intravenous (IV) bolus injection, we can determine the concentration of the drug in the plasma at any given time. This calculation is achieved using a specific equation that integrates the values of Vmax and KM.
We can also...
Following the administration of a single intravenous (IV) bolus injection, we can determine the concentration of the drug in the plasma at any given time. This calculation is achieved using a specific equation that integrates the values of Vmax and KM.
We can also...
36
One-Compartment Open Model for IV Bolus Administration: General Considerations
148
The one-compartment model is a pharmacokinetic tool that models the body as a single, uniform compartment, facilitating the understanding of drug distribution and elimination. This model is particularly beneficial for intravenous (IV) bolus administration, where the drug rapidly circulates throughout the body.
The drug's presence in the body is defined by an equation representing the difference between the rates of drug entry and exit. Key parameters—elimination rate constant,...
The drug's presence in the body is defined by an equation representing the difference between the rates of drug entry and exit. Key parameters—elimination rate constant,...
148
Antipsychotic Drugs: Typical and Atypical Agents
146
Antipsychotic drugs are classified into first-generation (typical) drugs including phenothiazines; and second-generation (atypical) drugs. Chlorpromazine hydrochloride (Thorazine), a phenothiazine derivative, broadly impacts the central, autonomic, and endocrine systems. This drug, along with typical agents like haloperidol (Haldol), primarily works by antagonizing D2 receptors, thus reducing dopaminergic neurotransmission. However, typical antipsychotics can cause side effects such as sedation...
146
Drug Delivery: Parenteral Route
372
The parenteral route is a critical method of drug administration. It delivers compounds directly into the systemic circulation and bypasses the gastrointestinal tract. This approach is particularly advantageous for drugs that exhibit poor absorption or instability when administered orally.
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
372


